Retrospective Study
Copyright ©The Author(s) 2020.
World J Gastrointest Endosc. Sep 16, 2020; 12(9): 276-284
Published online Sep 16, 2020. doi: 10.4253/wjge.v12.i9.276
Table 2 Characteristics of the 45 gastric cancer after Helicobacter pylori eradication
CharacteristicsTotal (n = 45)Single (n = 38)Multiple (n = 7)P value
Mean age (range), yr67.0 (43-86)65.6 (43-86)74.7 (63-84)0.039a
Sex, n (%)0.61
Female17 (37.7)15 (39.4)2 (28.5)
Male28 (62.2)23 (60.5)5 (71.4)
Kyoto score, average4.023.815.140.016a
Atrophic gastritis, score, n (%)1.711.652.000.77
None, 01 (2.22)1 (2.63)0
C-1, 0000
C-2, 17 (15.5)7 (18.4)0
C-3, 14 (8.88)4 (10.5)0
O-1, 27 (15.5)6 (15.7)1 (14.2)
O-2, 27 (15.5)6 (15.7)1 (14.)
O-3, 219 (42.2)14 (36.8)5 (71.4)
Intestinal metaplasia, score, n (%)1.281.152.000.048a
None, 012 (26.6)12 (31.5)0
Antrum, 18 (17.7)8 (21.0)0
Corpus, 225 (55.5)18 (47.3)7 (100)
Enlarged folds, score, n (%)0.060.0700.44
None, 042 (93.3)35 (92.1)7 (100)
Present, 13 (6.66)3 (7.89)0
Nodularity, score, n (%)0001.00
None, 045 (100)38 (100)7 (100)
Present, 1000
Diffuse redness, score, n (%)0.950.921.140.65
None, 03 (6.66)3 (7.89)0
With RAC, 141 (91.1)35 (92.1)6 (85.7)
Without RAC, 21 (2.22)01 (14.2)
Map like redness, yes27 (58.6)22 (56.4)5 (71.4)0.68
Mean size (range), mm14.8 (1.0-120)15.5 (1-120)11.1 (1.0-35)0.46
Pathology, n (%)
Intestinal type42 (93.3)35 (92.1)7 (100)0.44
Diffuse type3 (6.66)3 (7.89)0
Stage, n (%)0.98
I43 (95.5)36 (94.7)7 (100)
II1 (2.22)1 (2.63)0
III1 (2.22)1 (2.63)0
IV000
Treatment for gastric cancer, n (%)
Endoscopy43 (95.5)36 (94.7)7 (100)0.54
Surgery2 (4.44)2 (5.26)0
Chemotherapy000
Best supportive care000